Industry: Pharmaceuticals, Biotechnology
EBI’s primary target market is a group of disorders commonly known as the systemic inflammatory response syndrome (“SIRS”), including the clinical condition known as sepsis. Of the various inflammatory disorders, sepsis causes the greatest negative economic and medical consequences. It is the leading cause of death in hospital intensive care units worldwide, costing the US healthcare system an estimated $18 billion per year, and causing 1,400 deaths per day in the developed countries of the world. In SIRS/sepsis the body’s immune system overreacts to an infection or other stress leading to severe organ damage and death. SIRS acts by triggering a series of chemical reactions in the body in a sequential, cascade,like process. In many cases, uncontrolled cascades result in ( www.expobio.com )
Exponential Biotherapies , Inc.
Brunswick Building, #133 7921 Jones Branch Drive
McLean, Virginia 22102
USA
Tel: (703) 883-3701
Fax: (703) 883-3704